Page 17 - Pharma Sector News Today

‘Government’s efforts to boost domestic production should be synchronised with reducing imports and upgrading technology’

Drug major Sun Pharmaceutical Industries on Wednesday said it has entered into a licensing agreement with Ferring Pharmaceuticals to commercialise innovative obstetric drug Caritec in India. One of the companys wholly-owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals Pvt Ltd -- a subsidiary of Switzerland-based Ferring Pharmaceuticals -- to commercialise a room temperature stable formulation of the obstetric drug Caritec in India, Sun Pharma said in a regula...

Read more about Drug firm Ipca Laboratories fourth quarter profit up 94% at Rs 161 crore on Business Standard. Shares of Ipca Laboratories were trading at Rs 2,132.30 per scrip on BSE, down 3.06 per cent from the previous close.

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Schlagwort(e): Generalversammlung Relief lädt zur ordentlichen Generalversammlung der RELIEF THERAPEUTICS Holding AG ein 27.05.2021 / 07:00 Relief lädt zur ordentlichen Generalversammlung der RELIEF THERAPEUTICS Holding AG ein Genf, Schweiz, 27. ...

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Schlagwort(e): Generalversammlung Relief lädt zur ordentlichen Generalversammlung der RELIEF THERAPEUTICS Holding AG ein 27.05.2021

Research Report: By Glass Type (Borosilicate, Fused-Silica), End User (Pharmaceutical and Biotech Companies, Biomedical Research Organizations, Medical) - Global Industry Forecast to 2030.New York, May 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Vials Market" - https://www.reportlinker.com/p06075957/?utm_source=GNW Due to the surging incidence of chronic and acute diseases, the pharmaceutical industry is booming. As many of the drugs are administe...

Read more about Health ministry panel vetting requests by six cos to make Mucormycosis drug on Business Standard. Development come amid fast spread of disease in various states and shortage of drugs to treat it; Rajasthan has already declared an epidemic

Read more about Pharma sectors Q4 results show moderate gains amid Covid-19 pandemic on Business Standard. The ongoing April-June quarter should see strong growth due to low base of last year

Exclusive content, features, opinions and comment - hand-picked by our editors, just for you. Pick 5 of your favourite companies. Get a daily email with all the news updates on them. Track the industry of your choice with a daily newsletter specific to that industry. Stay on top of your investments. Track stock prices in your portfolio. NOTE : The monthly duration product is an auto renewal based product. Once subscribed, subject to your c...

The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20. Total revenue from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing. For the entire 2020-21 fiscal year, the drug maker reported a consolidated net profit of Rs 2,389 crore as against Rs 1,500 crore in the previous year. Total revenue from operations for the last fiscal year rose to Rs 19,160 crore as against Rs 17,132 cr...